Apoptosis induced by synthetic retinoic acid CD437 on human melanoma A375 cells involves RIG-I pathway

Min Pan1, Songmei Geng, Shengxiang Xiao

  • 1Department of Dermatology, Affiliated Hospital of Qingdao University Medical College, 16 Jiangsu Road, 266003, Qingdao, Shandong, People's Republic of China.

Insights

The synthetic retinoid CD437 induces apoptosis in melanoma cells by activating the NF-kappaB pathway, involving RIG-I and VISA. This discovery offers potential for new melanoma treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Human malignant melanoma exhibits significant resistance to current pharmacological treatments.
  • Retinoids are a class of compounds with potential anti-cancer properties.
  • Understanding the molecular mechanisms of retinoid action is crucial for developing effective therapies.

Purpose of the Study:

  • To evaluate the anti-tumor effects of the synthetic retinoid CD437 on the A375 human melanoma cell line.
  • To elucidate the molecular pathways involved in CD437-induced apoptosis.
  • To investigate the role of RIG-I (retinoic acid inducible gene I) and VISA in CD437's mechanism of action.

Main Methods:

  • Cell morphology analysis to assess apoptosis.
  • NF-kappaB-luciferase reporter assay to measure transcription factor activation.
  • Inhibition of the RIG-I pathway using hepatitis C virus (HCV) non-structural (NS)3/4A to cleave VISA.

Main Results:

  • CD437 treatment induced significant apoptosis in A375 melanoma cells.
  • Apoptosis induction by CD437 was dependent on the activation of the NF-kappaB transcription factor.
  • Blocking the RIG-I pathway via VISA cleavage inhibited CD437-induced NF-kappaB activation and apoptosis.

Conclusions:

  • CD437 demonstrates anti-tumor activity against melanoma by promoting apoptosis.
  • The RIG-I-VISA-NF-kappaB signaling axis is critical for CD437's anti-melanoma effects.
  • RIG-I may serve as a valuable biomarker in retinoid-based cancer chemoprevention and treatment strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...